CNX Therapeutics appoints Jeremy Devaney as Vice President, Commercial Operations
CNX Therapeutics is delighted to announce that Jeremy Devaney has joined CNX Therapeutics as Vice President, Commercial Operations.
Jeremy will be leading the commercial and supply chain teams at CNX, both in direct markets and working closely with our strategic partners. Jeremy has worked in the UK & European pharmaceutical industry for over 20 years, and brings extensive sales and business development experience. Jeremy will lead the company’s commercial strategy and business units as we strive to achieve our goal to be a leading European specialty pharma provider of essential medicines.
Jeremy says “I am honoured and truly excited to be joining CNX. The company’s unique business model and talented team of people will assist me in steering the business to further grown and expansion”.